{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:54:47Z","timestamp":1755795287641,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,5,25]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The relative safety of percutaneous left ventricular assist device (pVAD) and intra-aortic balloon pump (IABP) in patients with cardiogenic shock after acute myocardial infarction remain unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Multiple databases were searched to identify articles comparing pVAD and IABP. An unadjusted OR was used to calculate hard clinical outcomes and mortality differences on a random effect model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seven studies comprising 26 726 patients (1110 in the pVAD group and 25 616 in the IABP group) were included. The odds of all-cause mortality (OR 0.57, 95% CI 0.47 to 0.68, p=&lt;0.00001) and need for revascularisation (OR 0.16, 95% CI, 0.07 to 0.38, p=&lt;0.0001) were significantly reduced in patients receiving pVAD compared with IABP. The odds of stroke (OR 1.12, 95% CI 0.14 to 9.17, p=0.91), acute limb ischaemia (OR=2.48, 95% CI 0.39 to 15.66, p=0.33) and major bleeding (OR 0.36, 95% CI 0.01 to 25.39, p=0.64) were not significantly different between the two groups. A sensitivity analysis based on the exclusion of the study with the largest weight showed no difference in the mortality difference between the two mechanical circulatory support devices.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In patients with acute myocardial infarction complicated by cardiogenic shock, there is no significant difference in the adjusted risk of all-cause mortality, major bleeding, stroke and limb ischaemia between the devices. Randomised trials are warranted to investigate further the safety and efficacy of these devices in patients with cardiogenic shock.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001662","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T12:42:04Z","timestamp":1623674524000},"page":"e001662","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative safety of percutaneous ventricular assist device and intra-aortic balloon pump in acute myocardial infarction-induced cardiogenic shock"],"prefix":"10.1136","volume":"8","author":[{"given":"Waqas","family":"Ullah","sequence":"first","affiliation":[{"name":"Internal Medicine, Jefferson Health\u2014Abington, Abington, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-332X","authenticated-orcid":false,"given":"Mohamed","family":"Zghouzi","sequence":"additional","affiliation":[{"name":"Internal Medicine, Detroit Medical Center, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mukhtar","sequence":"additional","affiliation":[{"name":"Internal Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Banisad","sequence":"additional","affiliation":[{"name":"Cardiology, Detroit Medical Center, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaith","family":"Alhatemi","sequence":"additional","affiliation":[{"name":"Cardiology, Detroit Medical Center, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[{"name":"Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Zahid","sequence":"additional","affiliation":[{"name":"Internal Medicine, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homam","family":"Moussa Pacha","sequence":"additional","affiliation":[{"name":"Cardiology, University of Texas McGovern Medical School, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delair","family":"Gardi","sequence":"additional","affiliation":[{"name":"Cardiology, Detroit Medical Center, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Chadi","family":"Alraies","sequence":"additional","affiliation":[{"name":"Cardiology, Detroit Medical Center, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"2025081710293795000_8.1.e001662.1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025081710293795000_8.1.e001662.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.613596"},{"key":"2025081710293795000_8.1.e001662.3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2025081710293795000_8.1.e001662.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht248"},{"key":"2025081710293795000_8.1.e001662.5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ejhf.779","article-title":"Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes","volume":"19","author":"Gustafsson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2025081710293795000_8.1.e001662.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.022"},{"key":"2025081710293795000_8.1.e001662.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(18)31287-7"},{"key":"2025081710293795000_8.1.e001662.8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2015.10.005","article-title":"Use of mechanical circulatory support in percutaneous coronary intervention in the United States","volume":"117","author":"Khera","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025081710293795000_8.1.e001662.9","first-page":"54","article-title":"Treating refractory cardiogenic shock with the TandemHeart and Impella devices: a single center experience","volume":"3","author":"Schwartz","year":"2012","journal-title":"Cardiol Res"},{"key":"2025081710293795000_8.1.e001662.10","doi-asserted-by":"publisher","DOI":"10.1067\/mva.1991.27611"},{"key":"2025081710293795000_8.1.e001662.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2015.03.040"},{"key":"2025081710293795000_8.1.e001662.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.065"},{"key":"2025081710293795000_8.1.e001662.13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock: matched-pair iabp-shock II trial 30-day mortality analysis","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"2025081710293795000_8.1.e001662.14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.amjcard.2018.07.011","article-title":"Meta-analysis and trial sequential analysis comparing percutaneous ventricular assist devices versus intra-aortic balloon pump during high-risk percutaneous coronary intervention or cardiogenic shock","volume":"122","author":"Rios","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025081710293795000_8.1.e001662.15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.acvd.2019.10.005","article-title":"Mechanical circulatory support with the Impella\u00ae LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: the IMPELLA-STIC randomized study","volume":"113","author":"Bochaton","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"2025081710293795000_8.1.e001662.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5243913","article-title":"Long-Term outcomes of extent of revascularization in complex high risk and indicated patients undergoing Impella-protected percutaneous coronary intervention: report from the Roma-Verona registry","volume":"2019","author":"Burzotta","year":"2019","journal-title":"J Interv Cardiol"},{"key":"2025081710293795000_8.1.e001662.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.098194"},{"key":"2025081710293795000_8.1.e001662.18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.23736\/S0026-4725.18.04678-9","article-title":"Impella-protected PCI: the clinical results achieved so far","volume":"66","author":"Pesarini","year":"2018","journal-title":"Minerva Cardioangiol"},{"key":"2025081710293795000_8.1.e001662.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-015-0119-9","article-title":"The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience","volume":"15","author":"Pieri","year":"2015","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:29:44Z","timestamp":1755451784000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6,14]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/openhrt-2021-001662"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001662","relation":{},"ISSN":["2053-3624"],"issn-type":[{"type":"electronic","value":"2053-3624"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}